Drug intelligence / Profile preview

1-[(3S)-5-phenyl-3-thiophen-2-yl-3H-1,4-benzodiazepin-2-yl]azetidin-3-ol

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is an experimental small molecule with the chemical formula C22H19N3OS and a molecular weight of approximately 373.47 g/mol[1][7]. It is structurally characterized as a benzodiazepine derivative containing both thiophene and azetidinol moieties. The compound has not been approved for any medical use in the US or elsewhere and does not have any known clinical indications or completed clinical trials[1]. Its mechanism of action, pharmacological activity, and therapeutic potential are not described in publicly available sources. It has been referenced as a ligand (VGA) in structural biology databases but without further pharmacological annotation[7].

Other names: 1-(5-phenyl-3-thiophen-2-yl-3H-1,4-benzodiazepin-2-yl)azetidin-3-ol1-[ (3S)-5-PHENYL - 3 - THIOPHEN - 2 - YL - 3H - 1,4-BENZODIAZEPIN - 2-YL ]AZETIDIN - 3-O L

Beyond the preview

Go deeper on 1-[(3S)-5-phenyl-3-thiophen-2-yl-3H-1,4-benzodiazepin-2-yl]azetidin-3-ol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-[(3S)-5-phenyl-3-thiophen-2-yl-3H-1,4-benzodiazepin-2-yl]azetidin-3-ol.

Explore the full profile